Nutan Sharma, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dystonic Disorders | 35 | 2024 | 353 | 5.430 |
Why?
|
Dystonia | 24 | 2024 | 376 | 4.740 |
Why?
|
Genetic Diseases, X-Linked | 14 | 2024 | 385 | 1.710 |
Why?
|
Molecular Chaperones | 14 | 2016 | 762 | 1.340 |
Why?
|
Globus Pallidus | 4 | 2017 | 248 | 1.060 |
Why?
|
GTP Cyclohydrolase | 3 | 2017 | 47 | 0.940 |
Why?
|
Dystonia Musculorum Deformans | 8 | 2016 | 158 | 0.910 |
Why?
|
Dysphonia | 3 | 2021 | 144 | 0.890 |
Why?
|
Deep Brain Stimulation | 8 | 2020 | 850 | 0.810 |
Why?
|
5' Untranslated Regions | 2 | 2013 | 256 | 0.720 |
Why?
|
Conversion Disorder | 2 | 2021 | 201 | 0.690 |
Why?
|
TATA-Binding Protein Associated Factors | 5 | 2020 | 103 | 0.630 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2021 | 1151 | 0.610 |
Why?
|
Parkinsonian Disorders | 5 | 2024 | 286 | 0.550 |
Why?
|
Transcription Factor TFIID | 6 | 2020 | 149 | 0.540 |
Why?
|
Torticollis | 3 | 2016 | 69 | 0.530 |
Why?
|
Chorea | 2 | 2016 | 80 | 0.480 |
Why?
|
Histone Acetyltransferases | 5 | 2020 | 332 | 0.460 |
Why?
|
Lewy Bodies | 4 | 2002 | 140 | 0.420 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2013 | 83 | 0.410 |
Why?
|
Brain Stem | 2 | 2021 | 853 | 0.400 |
Why?
|
Anti-Dyskinesia Agents | 2 | 2014 | 24 | 0.390 |
Why?
|
Tourette Syndrome | 2 | 2025 | 400 | 0.370 |
Why?
|
DNA Repeat Expansion | 3 | 2024 | 74 | 0.360 |
Why?
|
Mutation | 15 | 2022 | 30198 | 0.350 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4108 | 0.340 |
Why?
|
DNA-Binding Proteins | 5 | 2021 | 9601 | 0.320 |
Why?
|
Parkinson Disease | 5 | 2018 | 2895 | 0.320 |
Why?
|
Basal Ganglia | 1 | 2012 | 549 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 5 | 2024 | 18071 | 0.310 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2024 | 16047 | 0.310 |
Why?
|
Synaptic Transmission | 3 | 2010 | 1175 | 0.290 |
Why?
|
Eukaryotic Initiation Factor-2 | 2 | 2020 | 177 | 0.290 |
Why?
|
Family Health | 1 | 2011 | 1253 | 0.260 |
Why?
|
Nuclear Proteins | 4 | 2016 | 5783 | 0.260 |
Why?
|
Age of Onset | 4 | 2025 | 3344 | 0.250 |
Why?
|
Brain | 11 | 2021 | 27171 | 0.240 |
Why?
|
Huntington Disease | 2 | 2022 | 1147 | 0.240 |
Why?
|
Nerve Tissue Proteins | 5 | 2012 | 4392 | 0.230 |
Why?
|
Botulinum Toxins | 1 | 2006 | 191 | 0.230 |
Why?
|
Sodium Oxybate | 1 | 2024 | 36 | 0.230 |
Why?
|
Deglutition Disorders | 2 | 2021 | 639 | 0.220 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7123 | 0.220 |
Why?
|
Tic Disorders | 1 | 2025 | 140 | 0.220 |
Why?
|
Retroelements | 3 | 2022 | 163 | 0.220 |
Why?
|
Codon | 2 | 2017 | 595 | 0.220 |
Why?
|
Substantia Nigra | 3 | 2002 | 346 | 0.210 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2015 | 103 | 0.210 |
Why?
|
eIF-2 Kinase | 3 | 2022 | 145 | 0.210 |
Why?
|
Mutation, Missense | 4 | 2021 | 2589 | 0.200 |
Why?
|
Open Reading Frames | 2 | 2017 | 820 | 0.190 |
Why?
|
Short Interspersed Nucleotide Elements | 2 | 2018 | 41 | 0.180 |
Why?
|
Humans | 71 | 2025 | 765968 | 0.180 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2023 | 216 | 0.180 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2021 | 84 | 0.180 |
Why?
|
Nervous System Diseases | 2 | 2024 | 1660 | 0.180 |
Why?
|
Neural Stem Cells | 3 | 2018 | 898 | 0.180 |
Why?
|
Corpus Striatum | 5 | 2016 | 1218 | 0.180 |
Why?
|
Algorithms | 1 | 2021 | 14071 | 0.170 |
Why?
|
Hyperkinesis | 2 | 2021 | 88 | 0.170 |
Why?
|
Speech Disorders | 1 | 2021 | 178 | 0.170 |
Why?
|
Histones | 2 | 2020 | 2584 | 0.170 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2022 | 172 | 0.160 |
Why?
|
RNA-Binding Proteins | 4 | 2022 | 1874 | 0.160 |
Why?
|
Male | 38 | 2025 | 363698 | 0.160 |
Why?
|
Penetrance | 1 | 2021 | 388 | 0.160 |
Why?
|
Movement Disorders | 1 | 2002 | 461 | 0.150 |
Why?
|
PubMed | 1 | 2019 | 131 | 0.150 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2108 | 0.150 |
Why?
|
Muscles | 1 | 2023 | 1578 | 0.150 |
Why?
|
Interferon Type I | 1 | 2022 | 567 | 0.150 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2017 | 94 | 0.140 |
Why?
|
Myelin Sheath | 1 | 2021 | 652 | 0.140 |
Why?
|
Spasms, Infantile | 1 | 2021 | 302 | 0.140 |
Why?
|
Epilepsy | 2 | 2021 | 3320 | 0.140 |
Why?
|
Voice | 1 | 2020 | 268 | 0.140 |
Why?
|
Stereotypic Movement Disorder | 1 | 2017 | 31 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2021 | 22223 | 0.140 |
Why?
|
Adult | 23 | 2025 | 223044 | 0.140 |
Why?
|
Phenotype | 8 | 2021 | 16721 | 0.140 |
Why?
|
Female | 32 | 2025 | 396112 | 0.130 |
Why?
|
Genetic Loci | 3 | 2021 | 2631 | 0.130 |
Why?
|
Ubiquitin | 1 | 2001 | 839 | 0.130 |
Why?
|
Motor Activity | 2 | 2010 | 2704 | 0.130 |
Why?
|
Receptors, Dopamine | 2 | 2015 | 291 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 691 | 0.130 |
Why?
|
Gene Expression | 5 | 2015 | 7584 | 0.130 |
Why?
|
Learning | 1 | 2005 | 1755 | 0.120 |
Why?
|
Rett Syndrome | 1 | 2017 | 163 | 0.120 |
Why?
|
Voice Disorders | 1 | 2019 | 286 | 0.120 |
Why?
|
Fibroblasts | 4 | 2020 | 4159 | 0.120 |
Why?
|
Lewy Body Disease | 3 | 2002 | 255 | 0.120 |
Why?
|
Receptors, Dopamine D2 | 2 | 2009 | 471 | 0.120 |
Why?
|
Synucleins | 4 | 2002 | 108 | 0.120 |
Why?
|
Dopamine | 4 | 2010 | 1582 | 0.120 |
Why?
|
Signal Transduction | 5 | 2020 | 23601 | 0.120 |
Why?
|
Carrier Proteins | 3 | 2002 | 4913 | 0.110 |
Why?
|
Adolescent | 12 | 2025 | 88835 | 0.110 |
Why?
|
Middle Aged | 18 | 2024 | 223009 | 0.110 |
Why?
|
Young Adult | 9 | 2025 | 59889 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1957 | 0.100 |
Why?
|
Genotype | 5 | 2016 | 13024 | 0.100 |
Why?
|
Tubulin | 1 | 2016 | 692 | 0.100 |
Why?
|
Sequence Alignment | 2 | 2013 | 2171 | 0.100 |
Why?
|
Neuronavigation | 1 | 2013 | 167 | 0.100 |
Why?
|
Neurology | 1 | 2020 | 785 | 0.100 |
Why?
|
Hippocampus | 2 | 2001 | 3775 | 0.100 |
Why?
|
Prefrontal Cortex | 2 | 2020 | 2224 | 0.100 |
Why?
|
Hand | 1 | 2017 | 909 | 0.100 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12807 | 0.090 |
Why?
|
Larynx | 1 | 2016 | 491 | 0.090 |
Why?
|
Research | 1 | 2020 | 1975 | 0.090 |
Why?
|
Catheters, Indwelling | 1 | 2013 | 438 | 0.090 |
Why?
|
Potassium Channels | 1 | 1993 | 534 | 0.090 |
Why?
|
Spasm | 1 | 2011 | 131 | 0.090 |
Why?
|
Nerve Growth Factors | 1 | 1993 | 565 | 0.090 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 533 | 0.090 |
Why?
|
Prosencephalon | 1 | 2012 | 305 | 0.090 |
Why?
|
Cell Nucleus | 2 | 2016 | 2867 | 0.090 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2010 | 412 | 0.090 |
Why?
|
Microscopy, Confocal | 4 | 2005 | 1966 | 0.090 |
Why?
|
Diffusion | 1 | 2012 | 808 | 0.080 |
Why?
|
Nucleic Acid Conformation | 1 | 2013 | 901 | 0.080 |
Why?
|
Acetylcholine | 2 | 2009 | 626 | 0.080 |
Why?
|
Mice, Transgenic | 8 | 2015 | 9550 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 2017 | 2086 | 0.080 |
Why?
|
Thalamus | 1 | 2016 | 1048 | 0.080 |
Why?
|
Laryngeal Diseases | 2 | 2024 | 248 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3430 | 0.080 |
Why?
|
Genes, Reporter | 1 | 2013 | 1524 | 0.080 |
Why?
|
Affect | 1 | 2017 | 1500 | 0.080 |
Why?
|
RNA, Messenger | 5 | 2018 | 12768 | 0.080 |
Why?
|
Spectrometry, Fluorescence | 2 | 2001 | 697 | 0.080 |
Why?
|
Neurons | 5 | 2018 | 9525 | 0.080 |
Why?
|
Motor Skills | 1 | 2012 | 516 | 0.080 |
Why?
|
Psychiatry | 1 | 2021 | 1714 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2485 | 0.070 |
Why?
|
Child | 11 | 2025 | 80564 | 0.070 |
Why?
|
Medical Records | 1 | 2013 | 1409 | 0.070 |
Why?
|
alpha-Synuclein | 4 | 2002 | 772 | 0.070 |
Why?
|
Genetic Testing | 2 | 2016 | 3595 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2013 | 17594 | 0.070 |
Why?
|
Child, Preschool | 6 | 2025 | 42500 | 0.070 |
Why?
|
Animals | 17 | 2021 | 168764 | 0.070 |
Why?
|
Base Sequence | 2 | 2018 | 12403 | 0.070 |
Why?
|
Introns | 2 | 2020 | 966 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 12976 | 0.070 |
Why?
|
Calcium Channels, N-Type | 1 | 2006 | 42 | 0.070 |
Why?
|
Probability | 1 | 2012 | 2475 | 0.070 |
Why?
|
Prognosis | 2 | 2021 | 29922 | 0.060 |
Why?
|
Neurogenesis | 1 | 2012 | 866 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 41649 | 0.060 |
Why?
|
Neuronal Plasticity | 2 | 2016 | 1445 | 0.060 |
Why?
|
Rotarod Performance Test | 1 | 2005 | 61 | 0.060 |
Why?
|
Immunohistochemistry | 5 | 2005 | 11022 | 0.060 |
Why?
|
Risk Assessment | 2 | 2021 | 24282 | 0.060 |
Why?
|
Gene Order | 2 | 2017 | 164 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2021 | 4260 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3737 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2012 | 2721 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4448 | 0.060 |
Why?
|
Energy Transfer | 2 | 2001 | 108 | 0.060 |
Why?
|
Disease Models, Animal | 8 | 2016 | 18293 | 0.060 |
Why?
|
Dysarthria | 1 | 2024 | 57 | 0.050 |
Why?
|
Quality of Life | 3 | 2020 | 13462 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2017 | 17075 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2024 | 65188 | 0.050 |
Why?
|
Apoptosis | 2 | 2020 | 9514 | 0.050 |
Why?
|
Gene Frequency | 1 | 2010 | 3624 | 0.050 |
Why?
|
Mice | 12 | 2021 | 81819 | 0.050 |
Why?
|
Aged | 9 | 2024 | 171117 | 0.050 |
Why?
|
Genetic Markers | 2 | 2016 | 2601 | 0.050 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2009 | 1140 | 0.050 |
Why?
|
Pedigree | 2 | 2022 | 4526 | 0.050 |
Why?
|
Twin Studies as Topic | 1 | 2002 | 103 | 0.050 |
Why?
|
Sex Chromosome Aberrations | 1 | 2002 | 116 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4671 | 0.050 |
Why?
|
Neuropil | 1 | 2001 | 31 | 0.050 |
Why?
|
Protein Conformation | 3 | 2011 | 3946 | 0.050 |
Why?
|
Alternative Splicing | 2 | 2018 | 1107 | 0.050 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.050 |
Why?
|
Interneurons | 1 | 2006 | 593 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3559 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2012 | 2410 | 0.050 |
Why?
|
Neurodegenerative Diseases | 2 | 2007 | 1087 | 0.050 |
Why?
|
Host Cell Factor C1 | 1 | 2021 | 35 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6853 | 0.050 |
Why?
|
YY1 Transcription Factor | 1 | 2021 | 60 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2018 | 1883 | 0.040 |
Why?
|
Ligases | 1 | 2002 | 330 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4247 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2022 | 292 | 0.040 |
Why?
|
Haplotypes | 2 | 2018 | 2728 | 0.040 |
Why?
|
Ornithine | 1 | 2020 | 80 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10850 | 0.040 |
Why?
|
Chromosomes, Human, X | 1 | 2002 | 319 | 0.040 |
Why?
|
Telomere-Binding Proteins | 1 | 2021 | 122 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6897 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2741 | 0.040 |
Why?
|
Intermediate Filaments | 1 | 2020 | 171 | 0.040 |
Why?
|
Muscle Hypotonia | 1 | 2021 | 167 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2002 | 624 | 0.040 |
Why?
|
Functional Laterality | 1 | 2006 | 2243 | 0.040 |
Why?
|
Leukocyte Elastase | 1 | 2020 | 113 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2016 | 13400 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2002 | 856 | 0.040 |
Why?
|
Gliosis | 1 | 2020 | 247 | 0.040 |
Why?
|
Heat-Shock Proteins | 1 | 2002 | 791 | 0.040 |
Why?
|
Gait | 1 | 2024 | 820 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2016 | 36532 | 0.040 |
Why?
|
Endocrine System Diseases | 1 | 2020 | 243 | 0.040 |
Why?
|
Gait Disorders, Neurologic | 1 | 2020 | 246 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 433 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1053 | 0.040 |
Why?
|
Excitatory Postsynaptic Potentials | 2 | 2009 | 366 | 0.040 |
Why?
|
Alu Elements | 1 | 2018 | 115 | 0.040 |
Why?
|
Minisatellite Repeats | 1 | 2018 | 162 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8237 | 0.040 |
Why?
|
Peroxidase | 1 | 2020 | 606 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10383 | 0.030 |
Why?
|
Antiparkinson Agents | 1 | 2018 | 185 | 0.030 |
Why?
|
Risk Factors | 3 | 2024 | 74840 | 0.030 |
Why?
|
Rare Diseases | 1 | 2022 | 635 | 0.030 |
Why?
|
Brain Mapping | 1 | 2012 | 6601 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 2020 | 591 | 0.030 |
Why?
|
Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2025 | 15880 | 0.030 |
Why?
|
Hospitals, General | 1 | 2021 | 802 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2021 | 604 | 0.030 |
Why?
|
Activating Transcription Factor 4 | 1 | 2016 | 86 | 0.030 |
Why?
|
Educational Status | 1 | 2024 | 2513 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 956 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2020 | 1385 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14652 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2002 | 1774 | 0.030 |
Why?
|
Electroencephalography | 1 | 2011 | 6273 | 0.030 |
Why?
|
Patch-Clamp Techniques | 2 | 2009 | 918 | 0.030 |
Why?
|
Time Factors | 2 | 2013 | 40065 | 0.030 |
Why?
|
Growth Substances | 1 | 2017 | 758 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26318 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2013 | 39193 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2021 | 14448 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2798 | 0.030 |
Why?
|
Family | 2 | 2018 | 3209 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2021 | 1153 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2025 | 2643 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2002 | 4618 | 0.030 |
Why?
|
Reference Values | 1 | 2001 | 4908 | 0.030 |
Why?
|
Transfection | 3 | 2011 | 5743 | 0.030 |
Why?
|
PC12 Cells | 1 | 1993 | 317 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2018 | 748 | 0.030 |
Why?
|
DNA | 2 | 2021 | 7202 | 0.030 |
Why?
|
Computer Simulation | 2 | 2020 | 6255 | 0.030 |
Why?
|
Incidence | 1 | 2011 | 21480 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2002 | 1892 | 0.030 |
Why?
|
Astrocytes | 1 | 2020 | 1345 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2012 | 224 | 0.020 |
Why?
|
Protein Binding | 2 | 2020 | 9296 | 0.020 |
Why?
|
Video Recording | 1 | 2017 | 969 | 0.020 |
Why?
|
DNA Repair | 1 | 2021 | 2048 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1744 | 0.020 |
Why?
|
Nuclear Localization Signals | 1 | 2011 | 79 | 0.020 |
Why?
|
Microglia | 1 | 2020 | 1372 | 0.020 |
Why?
|
Molecular Weight | 1 | 1993 | 2163 | 0.020 |
Why?
|
Infant | 1 | 2013 | 36386 | 0.020 |
Why?
|
Cell Shape | 1 | 2012 | 373 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1724 | 0.020 |
Why?
|
Demography | 1 | 2016 | 1641 | 0.020 |
Why?
|
Cell Fractionation | 1 | 2011 | 243 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2260 | 0.020 |
Why?
|
Sex Factors | 1 | 2025 | 10603 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1740 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6203 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2011 | 457 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12437 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5747 | 0.020 |
Why?
|
Nomifensine | 1 | 2010 | 14 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 2012 | 616 | 0.020 |
Why?
|
Parents | 1 | 2024 | 3592 | 0.020 |
Why?
|
Dimerization | 1 | 2011 | 880 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13632 | 0.020 |
Why?
|
Microdialysis | 1 | 2010 | 156 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2020 | 81514 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2669 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 1936 | 0.020 |
Why?
|
Acetylcholinesterase | 1 | 2009 | 150 | 0.020 |
Why?
|
Miniature Postsynaptic Potentials | 1 | 2009 | 17 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3141 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3067 | 0.020 |
Why?
|
Inhibitory Postsynaptic Potentials | 1 | 2009 | 61 | 0.020 |
Why?
|
Amphetamine | 1 | 2010 | 222 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2012 | 912 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1823 | 0.020 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2010 | 287 | 0.020 |
Why?
|
Cytosol | 1 | 2011 | 885 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3615 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3449 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6493 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2476 | 0.020 |
Why?
|
Radioligand Assay | 1 | 2007 | 364 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5786 | 0.020 |
Why?
|
Proteins | 1 | 2021 | 5995 | 0.020 |
Why?
|
Plasmids | 1 | 2011 | 2274 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 1526 | 0.020 |
Why?
|
Kinetics | 1 | 1993 | 6274 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2012 | 1410 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2007 | 1140 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2011 | 1394 | 0.020 |
Why?
|
Antibodies | 1 | 1993 | 2417 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3655 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 18973 | 0.010 |
Why?
|
Cell Division | 1 | 2012 | 4475 | 0.010 |
Why?
|
Presynaptic Terminals | 1 | 2007 | 297 | 0.010 |
Why?
|
Epitopes | 1 | 2011 | 2523 | 0.010 |
Why?
|
Cell Membrane | 1 | 1993 | 3634 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 788 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 6113 | 0.010 |
Why?
|
Dopamine Agonists | 1 | 2006 | 346 | 0.010 |
Why?
|
Transgenes | 1 | 2007 | 1015 | 0.010 |
Why?
|
Gestational Age | 1 | 2012 | 3609 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2006 | 686 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2009 | 1180 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59489 | 0.010 |
Why?
|
Rats | 2 | 2002 | 23707 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 2005 | 1600 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22332 | 0.010 |
Why?
|
Gene Library | 1 | 2005 | 1067 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9443 | 0.010 |
Why?
|
Models, Molecular | 1 | 2011 | 5379 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2012 | 3607 | 0.010 |
Why?
|
Inclusion Bodies | 1 | 2002 | 277 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15842 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5929 | 0.010 |
Why?
|
Cell Movement | 1 | 2012 | 5194 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2001 | 425 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2001 | 528 | 0.010 |
Why?
|
COS Cells | 1 | 2002 | 1136 | 0.010 |
Why?
|
Ligands | 1 | 2007 | 3273 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1430 | 0.010 |
Why?
|
Synapses | 1 | 2009 | 1754 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5876 | 0.010 |
Why?
|
Action Potentials | 1 | 2006 | 1838 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2002 | 2548 | 0.010 |
Why?
|
Protein Folding | 1 | 2002 | 869 | 0.010 |
Why?
|
Cell Line | 2 | 2002 | 15543 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18380 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1679 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10729 | 0.010 |
Why?
|
United States | 1 | 2024 | 72903 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2001 | 3051 | 0.010 |
Why?
|
Blotting, Western | 1 | 2001 | 5020 | 0.010 |
Why?
|
Transcription Factors | 1 | 2012 | 12131 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8102 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4958 | 0.010 |
Why?
|
Glioma | 1 | 2001 | 3493 | 0.000 |
Why?
|
Alzheimer Disease | 1 | 2002 | 8730 | 0.000 |
Why?
|